Radiomics-Based Phenotyping for Treatment Optimization of HER2+ Breast Cancer A second Ignition Award is going to ... Launching a Multiplex BRCA1/RAD51C ddPCR Methylation Assay as a Clinical HRD Test ...

Previous work from other laboratories showed that PARP inhibitors are particularly toxic to cells with defects in the homologous recombination (HR) repair pathway, including breast and ... resistance ...

A new genetic study from researchers at Michigan State University could help scientists gain a deeper understanding of where ...

Breast cancer treatments, while life-saving, can impact a woman's fertility. Chemotherapy and radiation therapy, in particular, can damage ovarian function, leading to difficulties conceiving.

The 2024 Innovator Award will cover four years of Ramanujam and her team’s work to reduce the burdens of cancer treatments on ...

A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and where cancer metastasizes.

October is Breast Cancer Awareness Month — a worldwide campaign to raise awareness of the devastating disease and promote early detection through screenings. About one in eight women will be ...

Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...

Breast canceris a significant global public health challenge, with 2.3 million new cases and 700,000 deaths every year. Approximately 80% of patients with primary breast cancer can be cured, if ...

Breast Cancer Awareness Month, held in October, promotes screening and prevention of this disease, which affects millions of women. The IAEA is helping to improve access to cancer care, including in ...